117 related articles for article (PubMed ID: 9536244)
21. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
Fulton B; Markham A
Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil.
Sollinger HW
Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
24. Mycophenolate mofetil in dermatology.
Orvis AK; Wesson SK; Breza TS; Church AA; Mitchell CL; Watkins SW
J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
[TBL] [Abstract][Full Text] [Related]
25. Mycophenolate mofetil.
Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
[TBL] [Abstract][Full Text] [Related]
26. Long-term safety of mycophenolate mofetil and cyclosporine: a review.
Buell C; Koo J
J Drugs Dermatol; 2008 Aug; 7(8):741-8. PubMed ID: 18720690
[TBL] [Abstract][Full Text] [Related]
27. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
Pedraz J; Daudén E; Delgado-Jiménez Y; García-Río I; García-Díez A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
[TBL] [Abstract][Full Text] [Related]
28. Mycophenolate mofetil for psoriasis.
Kirby B; Yates VM
Br J Dermatol; 1998 Aug; 139(2):357. PubMed ID: 9767269
[No Abstract] [Full Text] [Related]
29. Widespread plaque psoriasis responsive to mycophenolate mofetil.
Tong DW; Walder BK
Australas J Dermatol; 1999 Aug; 40(3):135-7. PubMed ID: 10439523
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
Am J Kidney Dis; 1999 Aug; 34(2):296-303. PubMed ID: 10430977
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis.
Herrera J; Ferrebuz A; MacGregor EG; Rodriguez-Iturbe B
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S218-25. PubMed ID: 17130265
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.
Reis A; Reinhard T; Voiculescu A; Kutkuhn B; Godehardt E; Spelsberg H; Althaus C; Sundmacher R
Br J Ophthalmol; 1999 Nov; 83(11):1268-71. PubMed ID: 10535855
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of erythrodermic psoriasis with mycophenolate mofetil.
Geilen CC; Tebbe B; Garcia Bartels C; Krengel S; Orfanos CE
Br J Dermatol; 1998 Jun; 138(6):1101-2. PubMed ID: 9747391
[No Abstract] [Full Text] [Related]
34. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.
Kobashigawa JA; Renlund DG; Gerosa G; Almenar L; Eisen HJ; Keogh AM; Lehmkuhl HB; Livi U; Ross H; Segovia J; Yonan N;
J Heart Lung Transplant; 2006 Aug; 25(8):935-41. PubMed ID: 16890114
[TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients.
Sollinger HW; Sundberg AK; Leverson G; Voss BJ; Pirsch JD
Transplantation; 2010 Feb; 89(4):446-51. PubMed ID: 20177347
[TBL] [Abstract][Full Text] [Related]
37. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil: a dermatologic perspective.
Mydlarski PR
Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
[TBL] [Abstract][Full Text] [Related]
40. Topical application of mycophenolate mofetil in plaque-type psoriasis.
Wohlrab J; Jahn K; Plaetzer M; Neubert R; Marsch WC
Br J Dermatol; 2001 Jun; 144(6):1263-4. PubMed ID: 11422055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
